FDA Recalls For June 10-Aug. 12
This article was originally published in The Tan Sheet
Executive Summary
Recalls reported by FDA for OTC drugs, nutritionals and personal care products.
You may also be interested in...
PharmaTech Recalls Highlight Supplement GMP Diligence For Marketers – CRN
PharmaTech customers recall liquid supplements, including products indicated for children, after CDC informs FDA that an antibiotic-resistant pathogen was found in a PharmaTech Rx drug. CRN says the recall should remind supplement firms about tracking supply chains and auditing contract manufacturers.
PharmaTech Adds Supplements To Recall Nearly A Month After Drugs
In addition to Major and Rugby supplement brands marketed by Cardinal Health subsidiary Harvard Health Group, PharmaTech's recall includes products it makes for the BProtected, Renew HC and Cytodetox brands.
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.